CHA
CVS icon

Carmichael Hill & Associates’s CVS Health CVS Stock Holding History

Carmichael Hill & Associates’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$151K Sell
2,403
-200
-8% -$11.7K 0.05% 218
2024
Q2 		$154K Hold
2,603
– – 0.06% 202
2024
Q1 		$208K Hold
2,603
– – 0.08% 176
2023
Q4 		$206K Sell
2,603
-312
-11% -$22.2K 0.09% 170
2023
Q3 		$204K Sell
2,915
-26
-0.9% -$1.84K 0.09% 161
2023
Q2 		$203K Buy
2,941
+420
+17% +$29.9K 0.09% 166
2023
Q1 		$187K Buy
2,521
+1
+0% +$84 0.09% 165
2022
Q4 		$235K Sell
2,520
-590
-19% -$56.9K 0.12% 140
2022
Q3 		$297K Buy
3,110
+352
+13% +$34.8K 0.16% 117
2022
Q2 		$256K Sell
2,758
-255
-8% -$24.9K 0.13% 132
2022
Q1 		$305K Buy
3,013
+276
+10% +$29K 0.14% 128
2021
Q4 		$282K Buy
2,737
+1
+0% +$92 0.13% 145
2021
Q3 		$232K Sell
2,736
-296
-10% -$24.8K 0.12% 152
2021
Q2 		$253K Buy
3,032
+2
+0.1% +$164 0.13% 138
2021
Q1 		$228K Buy
3,030
+3
+0.1% +$219 0.13% 143
2020
Q4 		$207K Buy
3,027
+123
+4% +$8K 0.12% 144
2020
Q3 		$170K Sell
2,904
-47
-2% -$2.92K 0.11% 148
2020
Q2 		$192K Buy
2,951
+3
+0.1% +$189 0.14% 128
2020
Q1 		$175K Buy
2,948
+52
+2% +$3.47K 0.15% 119
2019
Q4 		$215K Buy
+2,896
New +$203K 0.15% 126
2018
Q4 		– Sell
-2,979
Closed -$235K – 111
2018
Q3 		$235K Buy
+2,979
New +$213K 0.23% 103
2018
Q1 		– Sell
-3,179
Closed -$230K – 120
2017
Q4 		$230K Buy
+3,179
New +$231K 0.25% 103

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Carmichael Hill & Associates's CVS Position: Q3 2024 in Review

Carmichael Hill & Associates reduced its CVS Health (CVS) stake by 7.7% in Q3 2024, selling an estimated $11.7K and leaving 2,403 shares worth $151K. The position accounts for 0.05% of the portfolio, ranked #218.

Carmichael Hill & Associates first reported a position in CVS in Q4 2017 and has held it in 22 quarters since. The position peaked at $305K in Q1 2022. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Carmichael Hill & Associates held 2,403 shares of CVS Health worth $151K as of Q3 2024.
  • Carmichael Hill & Associates sold 200 CVS Health shares in Q3 2024, an estimated $11.7K.
  • CVS Health made up 0.05% of Carmichael Hill & Associates's portfolio in Q3 2024, its #218 holding.
  • Carmichael Hill & Associates first reported a position in CVS Health in Q4 2017 and has held it in 22 quarters since.
  • Carmichael Hill & Associates's CVS Health position peaked at $305K in Q1 2022.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.